OrigoGEN was born out of the coalescence of ideas, necessity, and innovation.

The idea: A group of university scientists and teachers realized that their collective research knowledge on the molecular basis of genetic diseases, such as Retinitis Pigmentosa or glaucoma, would allow them to provide precise molecular diagnoses for patients and their families.

The necessity: Many families have one or more members that are affected by genetic diseases. In many cases they were diagnosed on the basis of clinical symptoms alone. The molecular diagnosis of genetic diseases is a powerful tool for the clinician, as it confirms the clinical diagnosis, and helps to classify patients. This, in turn, offers a more accurate prognosis and helps the doctor to prescribe the most appropriate treatment.

The innovation: The public release of the human genome sequence, together with the development of a host of accompanying high-throughput technologies, has opened new avenues for molecular diagnoses, and consequently, novel perspectives for therapy.

The team
Roser Gonzàlez PhD. Professor in Genetics. Universitat de Barcelona. 20 years experience in the study of the molecular and genetic basis of retinal dystrophies.

Gemma Marfany PhD. Associate Professor in Genetics. Universitat de Barcelona. 10 years experience in the study of the molecular and genetic basis of retinal dystrophies.

Esther Pomares. Researcher. Universitat de Barcelona. 5 years experience in the study of the molecular and genetic basis of retinal dystrophies.